DK1323728T3 - Fremgangsmåde til diagnosticering af Alzheimers sygdom på basis af et genstransskriptionsmönster - Google Patents

Fremgangsmåde til diagnosticering af Alzheimers sygdom på basis af et genstransskriptionsmönster

Info

Publication number
DK1323728T3
DK1323728T3 DK03075068T DK03075068T DK1323728T3 DK 1323728 T3 DK1323728 T3 DK 1323728T3 DK 03075068 T DK03075068 T DK 03075068T DK 03075068 T DK03075068 T DK 03075068T DK 1323728 T3 DK1323728 T3 DK 1323728T3
Authority
DK
Denmark
Prior art keywords
disease
gene transcription
disease based
diagnosing alzheimer
transcription pattern
Prior art date
Application number
DK03075068T
Other languages
Danish (da)
English (en)
Inventor
Praveen Sharma
Anders Loenneborg
Original Assignee
Diagenic As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diagenic As filed Critical Diagenic As
Application granted granted Critical
Publication of DK1323728T3 publication Critical patent/DK1323728T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK03075068T 1997-04-30 1998-04-30 Fremgangsmåde til diagnosticering af Alzheimers sygdom på basis af et genstransskriptionsmönster DK1323728T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO972006A NO972006D0 (no) 1997-04-30 1997-04-30 Ny metode for diagnose av sykdommer
PCT/GB1998/001261 WO1998049342A1 (fr) 1997-04-30 1998-04-30 Procede servant a preparer un type standard de produit de transcription genetique de diagnostic

Publications (1)

Publication Number Publication Date
DK1323728T3 true DK1323728T3 (da) 2009-03-02

Family

ID=19900683

Family Applications (2)

Application Number Title Priority Date Filing Date
DK03075068T DK1323728T3 (da) 1997-04-30 1998-04-30 Fremgangsmåde til diagnosticering af Alzheimers sygdom på basis af et genstransskriptionsmönster
DK98919350T DK0979308T3 (da) 1997-04-30 1998-04-30 Fremgangsåde til fremstilling af et diagnostisk standard gen-transkriptmönster

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK98919350T DK0979308T3 (da) 1997-04-30 1998-04-30 Fremgangsåde til fremstilling af et diagnostisk standard gen-transkriptmönster

Country Status (13)

Country Link
US (4) US6720138B2 (fr)
EP (3) EP0979308B1 (fr)
JP (1) JP4163758B2 (fr)
AT (2) ATE286143T1 (fr)
AU (1) AU7222698A (fr)
CY (1) CY1108716T1 (fr)
DE (2) DE69828392T2 (fr)
DK (2) DK1323728T3 (fr)
ES (2) ES2230688T3 (fr)
HK (1) HK1026003A1 (fr)
NO (2) NO972006D0 (fr)
PT (2) PT1323728E (fr)
WO (1) WO1998049342A1 (fr)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO972006D0 (no) * 1997-04-30 1997-04-30 Forskningsparken I Aas As Ny metode for diagnose av sykdommer
CA2702148C (fr) * 1999-01-06 2014-03-04 Genenews Inc. Methode de profilage de l'expression genique d'un sujet humain atteint d'une maladie infectieuse
US20060134635A1 (en) * 2001-02-28 2006-06-22 Chondrogene Limited Method for the detection of coronary artery disease related gene transcripts in blood
US20040265868A1 (en) * 1999-01-06 2004-12-30 Chondrogene Limited Method for the detection of depression related gene transcripts in blood
US20050003394A1 (en) * 1999-01-06 2005-01-06 Chondrogene Limited Method for the detection of rheumatoid arthritis related gene transcripts in blood
US20040248170A1 (en) * 1999-01-06 2004-12-09 Chondrogene Limited Method for the detection of hyperlipidemia related gene transcripts in blood
US20070031841A1 (en) * 2001-02-28 2007-02-08 Choong-Chin Liew Method for the detection of gene transcripts in blood and uses thereof
US20050123938A1 (en) * 1999-01-06 2005-06-09 Chondrogene Limited Method for the detection of osteoarthritis related gene transcripts in blood
US20040241728A1 (en) * 1999-01-06 2004-12-02 Chondrogene Limited Method for the detection of lung disease related gene transcripts in blood
US20040248169A1 (en) * 1999-01-06 2004-12-09 Chondrogene Limited Method for the detection of obesity related gene transcripts in blood
US20040241726A1 (en) * 1999-01-06 2004-12-02 Chondrogene Limited Method for the detection of allergies related gene transcripts in blood
US7473528B2 (en) 1999-01-06 2009-01-06 Genenews Inc. Method for the detection of Chagas disease related gene transcripts in blood
US6365376B1 (en) * 1999-02-19 2002-04-02 E. I. Du Pont De Nemours And Company Genes and enzymes for the production of adipic acid intermediates
ATE507303T1 (de) * 1999-03-10 2011-05-15 Cold Spring Harbor Lab Genchiptechnologie zur bestimmung von gedächtnisgenen
US7005256B1 (en) 1999-03-10 2006-02-28 Cold Spring Harbor Laboratory Gene chip technology for determining memory genes
WO2000070099A2 (fr) * 1999-05-19 2000-11-23 Mitokor Expression genique differente dans des regions specifiques du cerveau, dans des maladies neurodegeneratives
EP1410011B1 (fr) 2001-06-18 2011-03-23 Rosetta Inpharmatics LLC Diagnostic et prevision du cancer du sein chez des patients
US20050064446A1 (en) * 2001-11-01 2005-03-24 Minerva Biotechnologies Corporation Detection of binding species with colloidal and non-colloidal structures
GB0227238D0 (en) * 2002-11-21 2002-12-31 Diagenic As Product and method
US7217807B2 (en) * 2002-11-26 2007-05-15 Rosetta Genomics Ltd Bioinformatically detectable group of novel HIV regulatory genes and uses thereof
FR2853907B1 (fr) * 2003-04-18 2007-08-03 Commissariat Energie Atomique Procede de preparation de fragments d'adn par fragmentation selective d'acides nucleiques et ses applications
US7888497B2 (en) * 2003-08-13 2011-02-15 Rosetta Genomics Ltd. Bioinformatically detectable group of novel regulatory oligonucleotides and uses thereof
WO2005076939A2 (fr) * 2004-02-09 2005-08-25 University Of Kentucky Research Foundation Test et procede de diagnostic et de traitement de la maladie d'alzheimer
US7593483B2 (en) * 2004-05-07 2009-09-22 Broadcom Corporation Nonlinear mapping in digital-to-analog and analog-to-digital converters
US7687616B1 (en) 2004-05-14 2010-03-30 Rosetta Genomics Ltd Small molecules modulating activity of micro RNA oligonucleotides and micro RNA targets and uses thereof
JP5697297B2 (ja) 2004-05-14 2015-04-08 ロゼッタ ジノミクス リミテッド マイクロｎａｓおよびその使用
US7795419B2 (en) * 2004-05-26 2010-09-14 Rosetta Genomics Ltd. Viral and viral associated miRNAs and uses thereof
EP2290073A3 (fr) 2004-05-28 2011-08-31 Asuragen, Inc. Procédés et compositions impliquant du microARN
GB0412301D0 (en) * 2004-06-02 2004-07-07 Diagenic As Product and method
US7867703B2 (en) * 2004-08-26 2011-01-11 Agilent Technologies, Inc. Element defined sequence complexity reduction
US7713693B1 (en) 2004-09-01 2010-05-11 University Of Louisiana At Monroe Human cancer cell specific gene transcript
EP2302055B1 (fr) 2004-11-12 2014-08-27 Asuragen, Inc. Procédés et compositions impliquant l'ARNmi et des molécules inhibitrices de l'ARNmi
CN103497993A (zh) * 2005-02-07 2014-01-08 基因信息公司 轻度骨关节炎生物标志物及其用途
US20070082350A1 (en) * 2005-02-09 2007-04-12 Philip Landfield Assay and method for diagnosing and treating alzheimer's disease
US20080075789A1 (en) * 2006-02-28 2008-03-27 The Regents Of The University Of California Genes differentially expressed in bipolar disorder and/or schizophrenia
WO2008036776A2 (fr) 2006-09-19 2008-03-27 Asuragen, Inc. Gènes régulés mir-15, mir-26, mir -31,mir -145, mir-147, mir-188, mir-215, mir-216 mir-331, mmu-mir-292-3p et voies de signalisation utiles comme cibles dans une intervention thérapeutique
US20090131348A1 (en) 2006-09-19 2009-05-21 Emmanuel Labourier Micrornas differentially expressed in pancreatic diseases and uses thereof
US20090029868A1 (en) * 2006-10-31 2009-01-29 Applera Corporation Expression signature in peripheral blood for detection of aortic aneurysm
WO2008073915A2 (fr) * 2006-12-08 2008-06-19 Asuragen, Inc. Microarn exprimés de manière différentielle en cas de leucémie et leurs utilisations
AU2007333107A1 (en) * 2006-12-08 2008-06-19 Asuragen, Inc. miR-21 regulated genes and pathways as targets for therapeutic intervention
AU2007333109A1 (en) * 2006-12-08 2008-06-19 Asuragen, Inc. Functions and targets of let-7 micro RNAs
EP2104734A2 (fr) * 2006-12-08 2009-09-30 Asuragen, INC. Gènes et voies génétiques régulés par le mir-20 en tant que cibles en vue d'une intervention thérapeutique
CA2671270A1 (fr) * 2006-12-29 2008-07-17 Asuragen, Inc. Genes et voies regules par mir-16 utiles comme cibles pour intervention therapeutique
US20090232893A1 (en) * 2007-05-22 2009-09-17 Bader Andreas G miR-143 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION
AU2008261951A1 (en) * 2007-06-08 2008-12-18 Asuragen, Inc. miR-34 regulated genes and pathways as targets for therapeutic intervention
WO2009036332A1 (fr) 2007-09-14 2009-03-19 Asuragen, Inc. Microarn exprimés de manière différentielle dans le cancer du col de l'utérus et leurs utilisations
WO2009052386A1 (fr) * 2007-10-18 2009-04-23 Asuragen, Inc. Micro arn exprimés différentiellement dans des maladies pulmonaires et leurs utilisations
WO2009070805A2 (fr) * 2007-12-01 2009-06-04 Asuragen, Inc. Gènes régulés par le mir-124 et cheminements servant de cibles pour une intervention thérapeutique
WO2009086156A2 (fr) * 2007-12-21 2009-07-09 Asuragen, Inc. Gènes et voies régulés par mir-10 servant de cibles dans le cadre d'une intervention thérapeutique
EP2260110B1 (fr) * 2008-02-08 2014-11-12 Asuragen, INC. Micro arn (mirna) exprimés différentiellement dans des noeuds lymphoïdes prélevés chez des patients atteints d'un cancer
EP2271757A2 (fr) * 2008-03-26 2011-01-12 Asuragen, INC. Compositions et procédés liés à mir-16 et à la thérapie contre le cancer de la prostate
WO2009126726A1 (fr) * 2008-04-08 2009-10-15 Asuragen, Inc Procédés et compositions pour diagnostiquer et moduler le papillomavirus humain (hpv)
WO2009137807A2 (fr) 2008-05-08 2009-11-12 Asuragen, Inc. Compositions et procédés liés à la modulation de miarn de néovascularisation ou d’angiogenèse
BRPI0914859A2 (pt) * 2008-08-27 2015-11-03 Lundbeck & Co As H método para diagnosticar um distúrbio afetivo, produto de programa de computador, computador, e, método para determinar uma probabilidade de que um indivíduo de teste exiba um sintoma de um distúrbio afetivo
WO2010056737A2 (fr) * 2008-11-11 2010-05-20 Mirna Therapeutics, Inc. Procédés et compositions impliquant des miarn dans des cellules souches cancéreuses
GB201000688D0 (en) 2010-01-15 2010-03-03 Diagenic Asa Product and method
EP2542678B1 (fr) 2010-03-04 2017-04-12 InteRNA Technologies B.V. Molécule de miarn définie par sa source et ses utilisations thérapeutiques pour cancers associés à l'emt
EP2591106A1 (fr) 2010-07-06 2013-05-15 InteRNA Technologies B.V. Miarn et ses utilisations diagnostiques et thérapeutiques pour des maladies ou des états associés au mélanome, ou pour des maladies ou des états associés à la voie braf activée
BR112013012265A2 (pt) 2010-11-17 2016-08-02 Asuragen Inc mirnas como biomarcadores para distinguir neoplasmas de tireoide benignos de malignos
EP2474617A1 (fr) 2011-01-11 2012-07-11 InteRNA Technologies BV MIR pour traiter une nouvelle angiogenèse
JP2014506789A (ja) 2011-02-03 2014-03-20 マーナ セラピューティクス インコーポレイテッド ｍｉＲ−１２４の合成模倣体
EP2681566A2 (fr) 2011-02-28 2014-01-08 University of Iowa Research Foundation Changements d'hormone antimullérienne dans la grossesse et prédiction d'évolution indésirable de grossesse et du sexe
US9746458B2 (en) * 2011-04-27 2017-08-29 Loma Linda University Medical Center Dynactin subunit p62 biomarker for neurological conditions
WO2013040251A2 (fr) 2011-09-13 2013-03-21 Asurgen, Inc. Méthodes et compositions incluant mir-135b, permettant de faire la distinction entre un cancer du pancréas et une maladie pancréatique bénigne
WO2013063519A1 (fr) 2011-10-26 2013-05-02 Asuragen, Inc. Procédés et compositions faisant intervenir des taux d'expression de miarn pour distinguer des kystes pancréatiques
WO2013063544A1 (fr) 2011-10-27 2013-05-02 Asuragen, Inc. Miarn en tant que biomarqueurs de diagnostic pour distinguer des tumeurs thyroïdiennes bénignes de malignes
WO2013064702A2 (fr) 2011-11-03 2013-05-10 Diagenic Asa Sondes pour le diagnostic et la surveillance d'une maladie neurodégénérative
WO2014007623A1 (fr) 2012-07-03 2014-01-09 Interna Technologies B.V. Portefeuille de diagnostic et ses utilisations
WO2014055117A1 (fr) 2012-10-04 2014-04-10 Asuragen, Inc. Micro-arn diagnostiques utilisés dans le diagnostic différentiel de lésions kystiques pancréatiques de découverte fortuite
US9758835B2 (en) 2013-03-15 2017-09-12 Baylor Research Institute Ulcerative colitis (UC)-associated colorectal neoplasia markers
CA2907377A1 (fr) 2013-03-15 2014-09-18 Baylor Research Institute Biomarqueurs de miarn a base de tissu et de sang pour le diagnostic, le pronostic et le potentiel predictif de metastases dans le cancer colorectal
US9944992B2 (en) 2013-03-15 2018-04-17 The University Of Chicago Methods and compositions related to T-cell activity
CN111566212A (zh) 2017-11-03 2020-08-21 因特尔纳技术有限公司 miRNA分子，等同物，安塔够妙或其来源用于治疗和/或诊断与神经元缺陷相关的病症和/或疾病或用于神经元生成和/或再生
WO2019104155A2 (fr) 2017-11-22 2019-05-31 The University Of Chicago Évaluation sonde chimique-dépendante de l'activité protéique et ses utilisations
EP3947727A4 (fr) 2019-04-05 2023-01-04 Board of Regents, The University of Texas System Procédés et applications pour le codage à barres de cellules
JP7566775B2 (ja) 2019-04-12 2024-10-15 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 筋肉量及び酸化的代謝を増加させるための組成物及び方法
IL299826A (en) 2020-07-15 2023-03-01 Cerebral Therapeutics Inc A medical device with a non-filtered CSF withdrawal path
US12605537B2 (en) 2022-02-15 2026-04-21 Biogen Ma Inc. Implantable medical device for use with or having recording electrode
WO2024028794A1 (fr) 2022-08-02 2024-02-08 Temple Therapeutics BV Méthodes de traitement de troubles de l'endomètre et de l'hyperprolifération ovarienne
WO2025248505A1 (fr) 2024-05-31 2025-12-04 Wayne State University Méthodes de traitement de troubles d'hyperprolifération endométriale et ovarienne

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4981783A (en) 1986-04-16 1991-01-01 Montefiore Medical Center Method for detecting pathological conditions
US6040138A (en) 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
US5800992A (en) 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
US5925525A (en) 1989-06-07 1999-07-20 Affymetrix, Inc. Method of identifying nucleotide differences
US5871928A (en) 1989-06-07 1999-02-16 Fodor; Stephen P. A. Methods for nucleic acid analysis
JP2802125B2 (ja) 1989-06-23 1998-09-24 キヤノン株式会社 核酸の検出方法
US5614192A (en) * 1989-07-19 1997-03-25 Connective Therapeutics, Inc. T cell receptor peptides as therapeutics for immune-related disease
US5474796A (en) * 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface
EP0534640B1 (fr) * 1991-09-23 1996-10-02 Pfizer Inc. Procédé pour détecter ARNm et ADN spécifiques dans les cellules
GB2260811B (en) 1991-10-23 1995-07-05 Yorkshire Cancer Research Camp Detection of malignant tumours
WO1993018143A1 (fr) 1992-03-04 1993-09-16 Synaptic Pharmaceutical Corporation ADN CODANT DES TRANSPORTEURS DE TAURINE ET D'ACIDE η-AMINOBUTYRIQUE ET SES EMPLOIS
US6114114A (en) * 1992-07-17 2000-09-05 Incyte Pharmaceuticals, Inc. Comparative gene transcript analysis
CA2148350A1 (fr) * 1992-10-29 1994-05-11 Carlo Croce Methodes de detection des micrometastases du cancer de la prostate
US5633137A (en) 1992-12-01 1997-05-27 The University Of South Florida Method for measuring specific gene expression: transcriptional activity per gene dose
US5677125A (en) 1994-01-14 1997-10-14 Vanderbilt University Method of detection and diagnosis of pre-invasive cancer
WO1997027317A1 (fr) 1996-01-23 1997-07-31 Affymetrix, Inc. Evaluation rapide de difference d'abondance d'acides nucleiques, avec un systeme d'oligonucleotides haute densite
US5830645A (en) * 1994-12-09 1998-11-03 The Regents Of The University Of California Comparative fluorescence hybridization to nucleic acid arrays
US5545531A (en) 1995-06-07 1996-08-13 Affymax Technologies N.V. Methods for making a device for concurrently processing multiple biological chip assays
US6156502A (en) 1995-12-21 2000-12-05 Beattie; Kenneth Loren Arbitrary sequence oligonucleotide fingerprinting
AU2189397A (en) 1996-02-08 1997-08-28 Affymetrix, Inc. Chip-based speciation and phenotypic characterization of microorganisms
AU4327697A (en) 1996-08-20 1998-03-06 Motorola, Inc. Method and apparatus for detecting predetermined molecular structures in a sample
WO1998024935A1 (fr) * 1996-12-06 1998-06-11 Urocor, Inc. DIAGNOSTIC D'ETAT PATHOLOGIQUE A L'AIDE DE PROFILS d'ARN MESSAGER
US6235474B1 (en) 1996-12-30 2001-05-22 The Johns Hopkins University Methods and kits for diagnosing and determination of the predisposition for diseases
US6190857B1 (en) * 1997-03-24 2001-02-20 Urocor, Inc. Diagnosis of disease state using MRNA profiles in peripheral leukocytes
NO972006D0 (no) * 1997-04-30 1997-04-30 Forskningsparken I Aas As Ny metode for diagnose av sykdommer
US5994076A (en) 1997-05-21 1999-11-30 Clontech Laboratories, Inc. Methods of assaying differential expression
AU9071098A (en) 1997-07-29 1999-02-22 Lambert C. J. Dorssers Breast cancer resistance genes, methods for their detection and uses thereof
US6607879B1 (en) * 1998-02-09 2003-08-19 Incyte Corporation Compositions for the detection of blood cell and immunological response gene expression
JP2002505431A (ja) 1998-02-25 2002-02-19 アメリカ合衆国 迅速な分子プロファイリングのための細胞アッセイ法
US6004755A (en) 1998-04-07 1999-12-21 Incyte Pharmaceuticals, Inc. Quantitative microarray hybridizaton assays
AU5779399A (en) 1998-08-21 2000-03-27 Naxcor Assays using crosslinkable immobilized nucleic acids
US6593084B2 (en) 1998-10-13 2003-07-15 Robert E. Bird Carcinogen assay
EP1121471A1 (fr) 1998-10-13 2001-08-08 Clontech Laboratories, Inc. Jeux ordonnes d'echantillons d'acide nucleique
WO2000024940A1 (fr) 1998-10-28 2000-05-04 Vysis, Inc. Reseaux cellulaires et methodes de detection et d'utilisation de marqueurs de troubles genetiques
WO2000026412A1 (fr) 1998-11-02 2000-05-11 Kenneth Loren Beattie Analyse d'acides nucleiques par hybridation en tandem ciblee sur des sequences
US20040248169A1 (en) * 1999-01-06 2004-12-09 Chondrogene Limited Method for the detection of obesity related gene transcripts in blood
US20040241726A1 (en) * 1999-01-06 2004-12-02 Chondrogene Limited Method for the detection of allergies related gene transcripts in blood
US20040241728A1 (en) * 1999-01-06 2004-12-02 Chondrogene Limited Method for the detection of lung disease related gene transcripts in blood
CA2702148C (fr) * 1999-01-06 2014-03-04 Genenews Inc. Methode de profilage de l'expression genique d'un sujet humain atteint d'une maladie infectieuse
US20040248170A1 (en) * 1999-01-06 2004-12-09 Chondrogene Limited Method for the detection of hyperlipidemia related gene transcripts in blood
US7473528B2 (en) * 1999-01-06 2009-01-06 Genenews Inc. Method for the detection of Chagas disease related gene transcripts in blood
US20050042630A1 (en) * 1999-01-06 2005-02-24 Chondrogene Limited Method for the detection of asthma related gene transcripts in blood
US20040265869A1 (en) * 1999-01-06 2004-12-30 Chondrogene Limited Method for the detection of type II diabetes related gene transcripts in blood
US20040265868A1 (en) * 1999-01-06 2004-12-30 Chondrogene Limited Method for the detection of depression related gene transcripts in blood
US20050003394A1 (en) * 1999-01-06 2005-01-06 Chondrogene Limited Method for the detection of rheumatoid arthritis related gene transcripts in blood
US20040241727A1 (en) * 1999-01-06 2004-12-02 Chondrogene Limited Method for the detection of schizophrenia related gene transcripts in blood
US20020169560A1 (en) * 2001-05-12 2002-11-14 X-Mine Analysis mechanism for genetic data

Also Published As

Publication number Publication date
US20050227286A1 (en) 2005-10-13
US6720138B2 (en) 2004-04-13
NO972006D0 (no) 1997-04-30
JP2001526534A (ja) 2001-12-18
US20130337446A1 (en) 2013-12-19
CY1108716T1 (el) 2014-04-09
DK0979308T3 (da) 2005-04-18
JP4163758B2 (ja) 2008-10-08
EP1323728A3 (fr) 2004-02-04
EP1323728A2 (fr) 2003-07-02
DE69828392D1 (de) 2005-02-03
NO20040371L (no) 1999-12-14
HK1057217A1 (en) 2004-03-19
US20040121390A1 (en) 2004-06-24
US20020022222A1 (en) 2002-02-21
EP0979308A1 (fr) 2000-02-16
EP2050825A1 (fr) 2009-04-22
ES2230688T3 (es) 2005-05-01
ATE412003T1 (de) 2008-11-15
ATE286143T1 (de) 2005-01-15
AU7222698A (en) 1998-11-24
WO1998049342A1 (fr) 1998-11-05
ES2316693T3 (es) 2009-04-16
NO327084B1 (no) 2009-04-20
PT979308E (pt) 2005-03-31
DE69840154D1 (de) 2008-12-04
HK1026003A1 (en) 2000-12-01
DE69828392T2 (de) 2005-12-01
PT1323728E (pt) 2009-01-23
EP0979308B1 (fr) 2004-12-29
EP1323728B1 (fr) 2008-10-22

Similar Documents

Publication Publication Date Title
DK1323728T3 (da) Fremgangsmåde til diagnosticering af Alzheimers sygdom på basis af et genstransskriptionsmönster
WO2000077260A8 (fr) Etablissement de profil genomique: procede rapide permettant d'analyser un echantillon biologique complexe afin de deceler la presence de nombreux types d'organismes
ATE333517T1 (de) Verfahren und sondenset zur erkennung von krebs
WO2000052204A3 (fr) Expression genique dans les tumeurs de la vessie
EP1215495A3 (fr) Procédé pour renforcer la spécificité clinique de la détection des tumeurs et leur précurseurs par la mesure simultanée d'au moins deux marqueurs moléculaires
WO2005023091A3 (fr) Procede de diagnostic prenatal non effractif
WO2001057275A3 (fr) Sondes d'acide nucleique a un seul exon derivees du genome humain utiles pour analyser l'expression genique dans le cerveau humain
DE60016178D1 (de) Verfahren zur diagnose und zur charakterisierung von schlaganfall
WO2002022879A3 (fr) Detection de l'instabilite des microsatellites et utilisation de celle-ci dans le diagnostic de tumeurs
WO2002074911A3 (fr) Identification des alterations de l'expression genetique qui accompagnent le processus de vieillissement des mammiferes
ATE318930T1 (de) Nukleinsäuresonden zur detektion von candida- spezies
WO2005054516A3 (fr) Sondes d'acides nucleiques peptidiques pour l'analyse de certaines especes staphylococcus
WO2004067715A3 (fr) Systeme et kit de test anonyme
WO2005027710A3 (fr) Procedes d'identification de sujets a risque pour le melanome et traitements correspondants
EP1132483A3 (fr) Méthode de diagnostic de la schizophrénie utilisant des indices objectifs
DE60025336D1 (de) Verfahren und kit zur früherkennung von krebs
FR2786787B1 (fr) Methode d'analyse in vitro d'un phenotype connu a partir d'un echantillon d'acides nucleiques
FI990380A7 (fi) Diagnostinen ja seulontamenetelmä
DE69535023D1 (de) Ein diagnose-verfahren und ein testsatz für die bestimmung des kell blutgruppln-nenotyps
DE60237406D1 (de) Aus einem Neuroblastom isolierte Nukleinsäuren
JPH04135498A (ja) 遺伝子検出方法
ATE369426T1 (de) Nukleinsäure- und aminosäuresequenzen von durch hämoglobin induzierbaren genen aus candida albicans und die verwendung dieser sequenzen in reagenzien zur diagnose von disseminierten candida albicans infektionen
ES2128265A1 (es) Kit genetico para la caracterizacion molecular de la enfermedad de alzheimer.
WO1999024607A3 (fr) DETECTION ET TYPAGE D'UN GENE iceA D'$i(HELICOBACTER PYLORY)
US20020012941A1 (en) Method for screening for unknown organisms